No. 24A1215

MSN Pharmaceuticals, Inc., et al v. Novartis Pharmaceuticals Corporation

Lower Court: Federal Circuit

Docketed: 2025-06-10

Status: Presumed Complete

Type: A

Experienced Counsel

Tags: after-arising-technology enablement-doctrine federal-circuit genus-claim patent-law patent-validity

Latest Conference: N/A

Question Presented (from Petition)

Question not identified.

Question Presented (AI Summary)

Whether a patent may validly claim a genus without describing or enabling species of the genus that utilize after-arising technology

Docket Entries

2025-06-11

Application (24A1215) granted by The Chief Justice extending the time to file until August 22, 2025.

2025-06-06

Application (24A1215) to extend the time to file a petition for a writ of certiorari from June 23, 2025 to August 22, 2025, submitted to The Chief Justice.

Main Document Proof of Service Main Document Proof of Service

Attorneys

MSN Pharmaceuticals, Inc., et al.

Amit Ramnik Vora — Kasowitz Benson Torres LLP, Petitioner